In a significant development, a new study led by Dr. Peter McCullough has proposed a method to neutralize the lingering effects of mRNA COVID-19 vaccines in the body. This discovery could bring relief to millions who are concerned about the potential long-term impacts of these vaccines.
The study, which is still in preprint, introduces an innovative approach using small interfering messenger RNA (siRNA) and ribonuclease targeting chimeras (RIBOTACs). These molecules have the potential to bind and deactivate the mRNA from the vaccines, enabling the body to clear it out more effectively.
How the Off-Switch Works
Dr. McCullough explains that siRNAs are not new to medical practice. Medications like Patisiran and Inclisiran already use these small interfering RNAs to target and neutralize specific mRNA molecules. These treatments are designed to last only a few days in the body, sufficient to bind and deactivate unwanted mRNA.
“The longevity of the encapsulated mRNA along with unlimited production of the damaging and potentially lethal Spike (S) protein calls for strategies to mitigate potential adverse effects,” the study’s abstract declares. By targeting and degrading residual vaccine mRNA, Dr. McCullough’s method could prevent uncontrolled spike protein production and reduce toxicity.
The Urgency of an Off-Switch
The study underscores the urgency of finding an “off switch” for mRNA vaccines, especially with new mRNA vaccines for respiratory syncytial virus (RSV) and influenza being approved. Dr. McCullough warns, “Without any way to turn off the messenger RNA, we think every single messenger RNA shot, because it’s been made synthetic and resistant to human breakdown, is going to make people progressively sick. We have to find a way to get this out of the body.”
Implications for Future Vaccines
This discovery has broader implications as mRNA technology is increasingly used in new vaccines. The ability to deactivate the mRNA could mitigate potential adverse effects and increase the safety profile of these innovative treatments.
Dr. McCullough hopes that molecular technology companies will take up this research and develop practical applications. “We’re gonna need an off switch for this,” he emphasizes. The strategic deactivation of mRNA vaccines could be a pivotal step in ensuring their safe and effective use in the future.
A Call for Action
The potential to neutralize mRNA vaccines represents a significant advancement in medical science. As this research progresses, it could pave the way for safer vaccine protocols and restore confidence in mRNA-based treatments.
For those concerned about the long-term effects of their COVID-19 vaccinations, this study offers hope and a tangible solution. The medical community and molecular technology companies are now urged to prioritise this research and develop the necessary tools to implement these findings.
➡️ Full Study
